NEOGENOMICS INC - Common stock ($0.001 par value) (NEO)
CUSIP: 64049M209
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common stock ($0.001 par value)
- Shares outstanding
- 129,801,451
- Total 13F shares
- 132,686,401
- Share change
- +3,035,529
- Total reported value
- $984,916,157
- Put/Call ratio
- 10%
- Price per share
- $7.42
- Number of holders
- 247
- Value change
- +$6,797,402
- Number of buys
- 111
- Number of sells
- 120
Quarterly Holders Quick Answers
What is CUSIP 64049M209?
CUSIP 64049M209 identifies NEO - NEOGENOMICS INC - Common stock ($0.001 par value) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 64049M209:
Top shareholders of NEO - NEOGENOMICS INC - Common stock ($0.001 par value) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
15%
from 13D/G
|
19,461,349
|
$228,865,463 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
13,828,355
|
$162,621,455 | — | 31 Dec 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
7.7%
|
10,035,063
|
$118,012,341 | — | 31 Dec 2025 | |
| Greenhouse Funds LLLP |
13F
13D/G
|
Company |
7.1%
from 13D/G
|
8,643,846
|
$101,651,629 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
4.8%
|
6,165,063
|
$63,315,197 | $0 | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
4.1%
|
5,297,528
|
$62,298,929 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
|
Company |
1.7%
from 13D/G
|
5,204,409
|
$61,203,850 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
4,978,292
|
$58,544,714 | — | 31 Dec 2025 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
|
Vanguard Portfolio Management |
5.9%
|
7,677,794
|
$56,969,231 | $0 | 31 Mar 2026 | |
| BRAIDWELL LP |
13F
|
Company |
3.6%
|
4,632,801
|
$54,481,740 | — | 31 Dec 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
3.1%
|
4,017,588
|
$49,135,101 | — | 31 Dec 2025 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
5.1%
|
6,610,272
|
$49,048,218 | $0 | 31 Mar 2026 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
3%
|
3,939,140
|
$46,324,000 | — | 31 Dec 2025 | |
| Douglas M. van Oort |
3/4/5
|
Director |
—
mixed-class rows
|
2,708,881
mixed-class rows
|
$45,677,027 | — | 01 Aug 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
3,176,644
|
$37,363,823 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
2.6%
|
3,317,169
|
$34,067,326 | $0 | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,471,738
|
$29,067,639 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
2,448,747
|
$28,801,373 | — | 31 Dec 2025 | |
| AMERICAN CAPITAL MANAGEMENT INC |
13F
|
Company |
1.8%
|
2,324,366
|
$27,334,544 | — | 31 Dec 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.7%
|
2,238,767
|
$26,328,000 | — | 31 Dec 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
2.8%
|
3,566,808
|
$26,073,366 | -$24,761,251 | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
2,126,049
|
$25,002,359 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.4%
|
1,798,939
|
$21,155,523 | — | 31 Dec 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
1.3%
|
1,732,029
|
$20,368,661 | — | 31 Dec 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.3%
|
1,694,051
|
$19,922,040 | — | 31 Dec 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.3%
|
1,631,135
|
$19,182,147 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,433,130
|
$16,853,609 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,423,088
|
$16,735,514 | — | 31 Dec 2025 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
1.1%
|
1,410,835
|
$16,591,418 | — | 31 Dec 2025 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
1.1%
|
1,388,221
|
$16,325,479 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
1,347,726
|
$15,849,258 | — | 31 Dec 2025 | |
| Christopher M. Smith |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
1,312,718
mixed-class rows
|
$15,690,205 | — | 23 Feb 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
1,307,471
|
$15,375,859 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.94%
|
1,217,152
|
$14,313,708 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.68%
|
885,530
|
$10,413,833 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.68%
|
877,949
|
$10,324,680 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.57%
|
740,017
|
$8,702,605 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.48%
|
616,909
|
$7,254,850 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
593,790
|
$6,982,970 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.45%
|
584,035
|
$6,868,251 | — | 31 Dec 2025 | |
| Mark Mallon |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
715,828
mixed-class rows
|
$6,768,458 | — | 01 Mar 2022 | |
| HighMark Wealth Management LLC |
13F
|
Company |
0.44%
|
567,334
|
$6,671,847 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.42%
|
539,157
|
$6,340,487 | — | 31 Dec 2025 | |
| Jeffrey Scott Sherman |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
497,051
mixed-class rows
|
$6,163,431 | +$112,322 | 21 Feb 2026 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.34%
|
447,703
|
$5,264,987 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.33%
|
427,504
|
$5,027,447 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
426,211
|
$5,012,242 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.33%
|
423,593
|
$4,981,454 | — | 31 Dec 2025 | |
| George Cardoza |
3/4/5
|
President & COO, Lab Ops |
—
mixed-class rows
|
304,659
mixed-class rows
|
$4,857,847 | — | 01 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.28%
|
357,256
|
$4,201,301 | — | 31 Dec 2025 |
Institutional Holders of NEOGENOMICS INC - Common stock ($0.001 par value) (NEO) as of Q1 2026
As of 31 Mar 2026,
NEOGENOMICS INC - Common stock ($0.001 par value) (NEO) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
132,686,401 shares.
The largest 10 holders included
BlackRock, Inc., First Light Asset Management, LLC, Greenhouse Funds LLLP, VANGUARD PORTFOLIO MANAGEMENT LLC, FIRST TRUST ADVISORS LP, VANGUARD CAPITAL MANAGEMENT LLC, BRAIDWELL LP, STATE STREET CORP, D. E. Shaw & Co., Inc., and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
247
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
255
Q1 2026 holders
247
Holder diff
-8
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.